[Antinuclear antibodies and serum complement in rheumatoid arthritis]. 1977

B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
March 1970, Connecticut medicine,
B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
January 1976, Nihon rinsho. Japanese journal of clinical medicine,
B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
January 1977, Godisen zbornik na Medicinskiot fakultet vo Skopje,
B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
April 1996, Anales espanoles de pediatria,
B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
January 1982, The Journal of rheumatology,
B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
October 1970, Polski tygodnik lekarski (Warsaw, Poland : 1960),
B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
January 1973, Sbornik vedeckych praci Lekarske fakulty Karlovy univerzity v Hradci Kralove. Supplementum,
B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
January 1977, Annales d'immunologie,
B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
August 1985, Vnitrni lekarstvi,
B Guceva, and M Polenaković, and M Grlickov, and D Cakalaroska, and H Marina
January 1972, Vutreshni bolesti,
Copied contents to your clipboard!